180 Wealth Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History

180 Wealth Advisors’s Portfolio RXRX Stock Details RXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$699K	Buy	190,562 +20,880	+12%	+$69.5K	0.07%	246
2026 Q1	$521K	Buy	169,682 +76,481	+82%	+$296K	0.06%	275
2025 Q4	$381K	Buy	93,201 +36,971	+66%	+$183K	0.04%	310
2025 Q3	$274K	Buy	56,230 +16,800	+43%	+$88.2K	0.03%	381
2025 Q2	$200K	Buy	39,430 +10,665	+37%	+$52.4K	0.03%	400
2025 Q1	$152K	Sell	28,765 -2,465	-8%	-$18K	0.02%	388
2024 Q4	$211K	Buy	31,230 +5,455	+21%	+$36.7K	0.03%	383
2024 Q3	$170K	Buy	25,775 +8,320	+48%	+$59.6K	0.03%	419
2024 Q2	$134K	Buy	+17,455	New	+$152K	0.02%	413

Other funds holding RXRX

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.6B AUM 29.42% 1-Year Est. Return

Accel Wealth Management Waverly, Iowa $444M AUM 31.14% 1-Year Est. Return

National Wealth Management Group Cincinnati, Ohio $323M AUM 39.23% 1-Year Est. Return

Wedmont Private Capital West Chester, Pennsylvania $3.65B AUM 26.64% 1-Year Est. Return

Integral Investment Advisors Turlock, California $454M AUM 21.42% 1-Year Est. Return

LVW Advisors Pittsford, New York $1.16B AUM 26.37% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return